ArticleCancer causes & control : CCC2025
Symptom attributions by cervical cancer patients attending specialized care at the Uganda cancer institute: a cross-sectional study.
Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Facilitators and Barriers to Cervical Cancer Screening Among Women in a Rural District of Northeastern Uganda, a Qualitative Study.Cancer management and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMost women in the low- and middle-income countries who develop cervical cancer are diagnosed at advanced stages following symptomatic presentations to healthcare professionals. This study sought to describe the symptoms experienced, symptoms' attributions, and factors associated with the perceived causes of the symptoms among a cohort of cervical cancer patients.
methodsThis was a cross-sectional study conducted at the Uganda Cancer Institute (UCI) during October 2019 to January 2020. Data were collected using a pre-tested semi-structured questionnaire and a data abstraction form for clinical variables in the patients' case notes and analyzed using STATA version 15.0. We used modified Poisson regression models with robust variance to determine socio-demographic and clinical characteristics associated with perceived causes of symptoms. We report prevalence ratios with accompanying 95% confidence intervals. Prevalence ratios were considered statistically significant when the two-sided p values < 0.05.
resultsWe collected data from 449 participants, with a median age of 49.0 (IQR = 42-58). More than half of the participants, 59.2% (n = 266) were diagnosed with early-stage (stages 1/2) cancer. Most participants recognized risk factors for cervical cancer as using hormonal family planning 91.3% (n = 410) and having many sexual partners 89.1% (n = 400). Initial symptoms experienced by the patients included vaginal discharge 78.6% (n = 353) and vaginal bleeding in between monthly periods, 48.3% (n = 217). More than half of the patients, 57.2% (n = 257) thought the symptoms experienced were due to sexually transmitted infections (STI), while only 5.6% (n = 25) of patients thought the initial symptoms were due to cancer. The socio-demographic factors significantly associated with the perceptions that symptoms were due to STIs included having formal education, i.e., secondary and tertiary levels of education with adjusted prevalence ratios (aPR) = 1.84(95% CI: 1.38-2.47) and aPR = 1.71(95% CI: 1.20-2.42), respectively, and being formally employed aPR = 1.19 (95% CI: 1.00-1.40).
conclusionWomen ought to be aware that cervical cancer may present as vaginal discharge or vaginal bleeding in between menstrual periods and should therefore seek care promptly when they develop such symptoms. Primary healthcare physicians need to avoid empirical treatment of every woman with vaginal discharge but rather conduct careful evaluations to properly assess the cervix for diagnoses.
Indexed as
Identifiers
40897989What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.